DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

Current stock price

109.46 USD
-0.46 (-0.42%)
At close:
109.46 USD
0 (0%)
After Hours:

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • DORM had a positive operating cash flow in the past year.
  • Each year in the past 5 years DORM has been profitable.
  • DORM had a positive operating cash flow in each of the past 5 years.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • DORM has a better Return On Assets (8.19%) than 87.80% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.82%, DORM belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
  • DORM's Return On Invested Capital of 13.20% is amongst the best of the industry. DORM outperforms 90.24% of its industry peers.
  • DORM had an Average Return On Invested Capital over the past 3 years of 11.36%. This is above the industry average of 9.26%.
  • The last Return On Invested Capital (13.20%) for DORM is above the 3 year average (11.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROIC 13.2%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • DORM has a better Profit Margin (9.59%) than 92.68% of its industry peers.
  • DORM's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.72%, DORM belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DORM has grown nicely.
  • The Gross Margin of DORM (42.14%) is better than 90.24% of its industry peers.
  • DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DORM Health Analysis

2.1 Basic Checks

  • DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DORM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DORM has been reduced compared to 5 years ago.
  • DORM has a better debt/assets ratio than last year.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • DORM has an Altman-Z score of 4.54. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
  • DORM's Altman-Z score of 4.54 is amongst the best of the industry. DORM outperforms 82.93% of its industry peers.
  • DORM has a debt to FCF ratio of 5.81. This is a neutral value as DORM would need 5.81 years to pay back of all of its debts.
  • DORM's Debt to FCF ratio of 5.81 is fine compared to the rest of the industry. DORM outperforms 60.98% of its industry peers.
  • DORM has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • DORM has a better Debt to Equity ratio (0.27) than 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Altman-Z 4.54
ROIC/WACC1.45
WACC9.11%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • DORM has a Current Ratio of 3.09. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
  • DORM has a Current ratio of 3.09. This is in the better half of the industry: DORM outperforms 75.61% of its industry peers.
  • A Quick Ratio of 1.14 indicates that DORM should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.14, DORM is in line with its industry, outperforming 41.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 1.14
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.72% on average per year.
  • DORM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.03%.
  • The Revenue has been growing by 14.28% on average over the past years. This is quite good.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 6.46% on average per year.
  • The Revenue is expected to grow by 5.64% on average over the next years.
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.34, which indicates a correct valuation of DORM.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 70.73% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.78. DORM is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 12.22, which indicates a correct valuation of DORM.
  • DORM's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. DORM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.34
Fwd PE 12.22
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • DORM's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DORM.
Industry RankSector Rank
P/FCF 43.66
EV/EBITDA 9
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)13.04
PEG (5Y)0.6
EPS Next 2Y5.42%
EPS Next 3Y-0.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (4/10/2026, 8:17:48 PM)

After market: 109.46 0 (0%)

109.46

-0.46 (-0.42%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners90.37%
Inst Owner Change0%
Ins Owners12.82%
Ins Owner Change2.74%
Market Cap3.30B
Revenue(TTM)2.13B
Net Income(TTM)204.19M
Analysts85.71
Price Target156.44 (42.92%)
Short Float %4.4%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.11%
Min EPS beat(2)-0.69%
Max EPS beat(2)2.92%
EPS beat(4)3
Avg EPS beat(4)12.48%
Min EPS beat(4)-0.69%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)22.38%
EPS beat(12)8
Avg EPS beat(12)10.5%
EPS beat(16)9
Avg EPS beat(16)7.26%
Revenue beat(2)0
Avg Revenue beat(2)-5.69%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)-9.98%
PT rev (3m)-11.6%
EPS NQ rev (1m)-6.42%
EPS NQ rev (3m)-23.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.06%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)-1.99%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 12.34
Fwd PE 12.22
P/S 1.55
P/FCF 43.66
P/OCF 29.07
P/B 2.24
P/tB 3.97
EV/EBITDA 9
EPS(TTM)8.87
EY8.1%
EPS(NY)8.95
Fwd EY8.18%
FCF(TTM)2.51
FCFY2.29%
OCF(TTM)3.77
OCFY3.44%
SpS70.59
BVpS48.94
TBVpS27.59
PEG (NY)13.04
PEG (5Y)0.6
Graham Number98.83
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROCE 17.81%
ROIC 13.2%
ROICexc 13.54%
ROICexgc 20.22%
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
FCFM 3.55%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
ROICexc(3y)11.65%
ROICexc(5y)10.5%
ROICexgc(3y)18.73%
ROICexgc(5y)16.69%
ROCE(3y)15.58%
ROCE(5y)14.81%
ROICexgc growth 3Y20.29%
ROICexgc growth 5Y5.06%
ROICexc growth 3Y25.64%
ROICexc growth 5Y0.33%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
F-Score8
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Debt/EBITDA 0.98
Cap/Depr 68.13%
Cap/Sales 1.78%
Interest Coverage 13.02
Cash Conversion 27.58%
Profit Quality 37.06%
Current Ratio 3.09
Quick Ratio 1.14
Altman-Z 4.54
F-Score8
WACC9.11%
ROIC/WACC1.45
Cap/Depr(3y)72.66%
Cap/Depr(5y)71.81%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)88.47%
Profit Quality(5y)65.95%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%
EBIT growth 1Y21.63%
EBIT growth 3Y27.72%
EBIT growth 5Y21.71%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.51%
FCF growth 3Y171.04%
FCF growth 5Y-11.13%
OCF growth 1Y-50.82%
OCF growth 3Y39.68%
OCF growth 5Y-5.65%

DORMAN PRODUCTS INC / DORM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 4 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


How profitable is DORMAN PRODUCTS INC (DORM) stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


What is the financial health of DORMAN PRODUCTS INC (DORM) stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


What is the earnings growth outlook for DORMAN PRODUCTS INC?

The Earnings per Share (EPS) of DORMAN PRODUCTS INC (DORM) is expected to grow by 0.95% in the next year.